Literature DB >> 5088588

[Pseudosarcomatous neoplasms of soft tissues].

O Meffert, H G Weber, H Buse, H Emmermann, H Uebel.   

Abstract

Entities:  

Mesh:

Year:  1971        PMID: 5088588     DOI: 10.1007/bf01251344

Source DB:  PubMed          Journal:  Langenbecks Arch Chir        ISSN: 0023-8236


× No keyword cloud information.
  18 in total

1.  [The overlooked, not recognized and wrongly interpreted bone tumor. I].

Authors:  H HELLNER
Journal:  Chirurg       Date:  1961-04       Impact factor: 0.955

2.  Proliferative myositis; a pseudosarcomatous reaction to injury: a report of seven cases.

Authors:  W H KERN
Journal:  Arch Pathol       Date:  1960-02

3.  [Problem of benign tumors].

Authors:  H HELLNER
Journal:  Langenbecks Arch Klin Chir Ver Dtsch Z Chir       Date:  1956

4.  Ossifying fibrosarcoma (extraskeletal osteogenic sarcoma) of thigh muscle; report of a case with recurrence and widespread metastases more than four and a half years after excision.

Authors:  W UMIKER; H L JAFFE
Journal:  Ann Surg       Date:  1953-11       Impact factor: 12.969

5.  Multiple cutaneous and subcutaneous lesions occurring simultaneously with hereditary polyposis and osteomatosis.

Authors:  E J GARDNER; R C RICHARDS
Journal:  Am J Hum Genet       Date:  1953-06       Impact factor: 11.025

6.  Chondrosarcoma of the extraskeletal soft tissues.

Authors:  A P STOUT; E W VERNER
Journal:  Cancer       Date:  1953-05       Impact factor: 6.860

7.  [Fasciitis nodularis pseudosarcomatosa].

Authors:  H Emmermann
Journal:  Chirurg       Date:  1968-08       Impact factor: 0.955

8.  [Clinical and therapeutic problems in synovial sarcoma].

Authors:  P E Böhme
Journal:  Zentralbl Chir       Date:  1967       Impact factor: 0.942

9.  Pseudosarcomatous fasciitis. Case report.

Authors:  D B Apfelberg; J L Teasley
Journal:  Plast Reconstr Surg       Date:  1968-09       Impact factor: 4.730

10.  Proliferative myositis. Report of thirty-three cases.

Authors:  F M Enzinger; F Dulcey
Journal:  Cancer       Date:  1967-12       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.